¦Â-Adrenergic agonist infusion during extracorporeal lung perfusion: Effects on glucose concentration in the perfusion fluid and on lung function

详细信息    查看全文

• 作者：Franco Valenza ; MD^a ; ^b ; ^{franco.valenza@unimi.it} ; Lorenzo Rosso ; MD^c ; Silvia Coppola ; MD^a ; Sara Froio ; MD^a ; Jacopo Colombo ; MD^a ; Roberto Dossi^a ; Jacopo Fumagalli^a ; Valentina Salice ; MD^a ; Marta Pizzocri ; MD^a ; Grazia Conte ; MD^d ; Stefano Gatti ; MD^d ; Luigi Santambrogio ; MD ; FRCP^c ; ^b ; Luciano Gattinoni ; MD ; FRCP^a ; ^b
• 关键词：Ex-vivo lung perfusion ; EVLP ; ¦Â-agonist ; glucose ; lung metabolism ; lung edema
• 刊名：The Journal of Heart and Lung Transplantation
• 出版年：2012
• 出版时间：May, 2012
• 年：2012
• 卷：31
• 期：5
• 页码：524-530
• 全文大小：495 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Background

We recently showed in a pig model of ex vivo lung perfusion (EVLP) that lung edema correlates with glucose consumption. We investigated whether salbutamol, a ¦Â-adrenergic receptor agonist known to upregulate fluid transport in the lung, modulates glucose concentration in the perfusate during EVLP.

Methods

Lungs from domestic pigs underwent normothermic EVLP. At the end of controlled reperfusion, lungs were ventilated and perfused for 60 minutes, then randomized to salbutamol (¦Â-Agonist) infusion or placebo (Control) for 180 minutes. Functional parameters were assessed.

Results

In the ¦Â-Agonist group, glucose concentration decreased over time more than corresponding Control values (analysis of variance [ANOVA], p = 0.05). Mean pulmonary artery pressure (mPAP) was 16 ¡À 1 mm Hg in the ¦Â-Agonist group vs 21 ¡À 1 mm Hg in the Controls (ANOVA p < 0.05). Baseline mPAP was correlated with the drop of mPAP after the ¦Â-agonist infusion (R² = 0.856, p < 0.05). Dynamic compliance dropped from 51 ¡À 10 to 31 ¡À 6 ml/cm H₂O in the ¦Â-Agonist group and from 60 ¡À 4 to 21 ¡À 3 ml/cm H₂O in the Control group (ANOVA, p < 0.05 ¦Â-agonist vs Control). The ¦¤ partial pressure of oxygen/fraction of inspired oxygen was 418 ¡À 15 and 393 ¡À 12 mm Hg in the ¦Â-Agonist and Control groups, respectively (t-test p = 0.106).

Conclusions

Glucose concentration in the perfusate was affected by salbutamol. Salbutamol was associated with lower pulmonary pressures and better lung mechanics. These data suggest a possible role for salbutamol as a pharmacologic adjunct during EVLP before transplantation.